Renalytix plc (RNLXY) Return on equity 2020–2023
Renalytix plc (RNLXY) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-654.6%FY2023 · since FY2020: -61.9% → -654.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -654.6% | -506.7 pp |
| FY2022 | -147.9% | -98.5 pp |
| FY2021 | -49.4% | +12.4 pp |
| FY2020 | -61.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More RNLXY financial trends
RNLXY RevenueRNLXY Net incomeRNLXY Net marginRNLXY Gross profitRNLXY Gross marginRNLXY Operating incomeRNLXY Operating marginRNLXY Operating cash flowRNLXY Free cash flowRNLXY Capital expendituresRNLXY Stock buybacksRNLXY Dividends paidRNLXY Total assetsRNLXY Total liabilitiesRNLXY Shareholders’ equityRNLXY overview →